Using custom made videos with the help of our creative artists.
Don’t miss a single one. Even while he sets up his desk and office, you can follow Dr. Grauci now right here on LinkedIn or on Instagram @ dr.grauci.
#disruptive#innovation
Please meet our latest addition to the team, the famed The National Institutes of Health scientist Dr. Grauci.
In his new role as Secondcell Bio’s Director at our National Institutes of Innovation, #drGrauci will lecture you on science and #innovation.
Come partner with us for Drug Discovery at Scale™ to win the global race to create and own IP for numerous new medical treatments and drugs.
Contact Secondcell Bio CEO Dr. Kambiz Shekdar seen here holding #researchballoons.
#chromovert#innovation#biotechnology
Like how the US government scaled-up DNA sequencing, once automated, to produce the 1st draft of the Human Genome, #Chromovert® Technology permits scale-up of drug discovery, now automated, to produce the 1st draft of IP for medical drugs corresponding to all genes.
NEWS! Biotech Venture in the UAE Validated by #IPO in the U.S. | Disruptive platform biotechnology at the center of a @secondcell#biotech venture in the UAE has been validated by an IPO filing in the United States. https://t.co/dClfbvNa7p #Chromovert#KambizShekdar
What's next for us? #Chromovert® is a validated technology: it has already been successfully applied to a range of commercial programs. Now, the technology is ready for “Drug discovery at Scale.”™ Read the paper: https://t.co/tWcGWbhW3j #kambizshedkar#abudhabi#dubai#uae
What makes #Chromovert so useful? Chromovert® increases the overall likelihood of success of the long & expensive process. Investments have a higher likelihood of return. Learn about the process for this #biotech tool: https://t.co/tWcGWaZMPb #abudhabi#dubai#uae#kambizshekdar
“Drug Discovery” is highly ineffective with industry-average failures of 98%, driving up the cost to produce new drugs to $1.8B each. Improvements are needed at all stages of the process. Enter #chromovert: https://t.co/tWcGWbhodL #abudhabi#UAE#biotechnology#kambizshekdar
Chromovert® Technology was used to create cell lines for a diversity of proteins. Read the influential publication of our technology spearheaded by @kambizshekdar here in Biotechnology Letters: https://t.co/tWcGWbhodL #cellengineering#chromovert#molecularbeacon#biotech
Cell engineering made easy.™ Drug discovery at scale.™ Use #Chromovert to scan millions of cells to detect and isolate even exceedingly rare, optimally engineered cells. Download the paper by #KambizShekdar: https://t.co/tWcGWbhW3j #biotech#pharma#molecularbeacon
On October 31, 2022 @secondcellbio signed its first term sheet for a partnership with #Emirati stakeholder to build a #biotech research in the UAE for “Drug Discovery at Scale.” Details of the transaction remain confidential for now. More info: https://t.co/n6pUzrptag #pharma
We are at the forefront of a new era in #biotech! @secondcellbio brings a new frontier with #Chromovert, a broadly-applicable platform technology developed by @KambizShekdar. Create cell lines for any cell type, any gene, any application. More: https://t.co/tWcGWaZMPb #pharma
Drug discovery at scale: the future is now. Learn how #Chromovert can transform your cell engineering needs for the next breakthroughs in curing disease. Read the groundbreaking research by @KambizShekdar https://t.co/tWcGWaZMPb #molecularbeacon#drugomics#biotech#pharma